Jensen Huang Founder, President and CEO at NVIDIA | Official website
NVIDIA AI Microservices for Drug Discovery and Digital Health are now available on AWS Marketplace, as announced by a spokesperson from NVIDIA. The integration of these services with AWS allows customers to access the cutting-edge technology offered by NVIDIA for drug discovery and digital health.
According to the NVIDIA spokesperson, "We are excited to offer NVIDIA AI Microservices for Drug Discovery and Digital Health on AWS Marketplace." This collaboration signifies a significant step in bringing advanced AI capabilities to the healthcare and pharmaceutical industries.
In response to the integration, an AWS spokesperson stated, "This integration brings the power of NVIDIA AI to AWS customers." By leveraging the NVIDIA AI Microservices on AWS, organizations can enhance their research and development efforts in drug discovery and digital health.
The partnership between NVIDIA and AWS signifies a commitment to innovation and collaboration in the healthcare and technology sectors. Customers can now benefit from the combined expertise of both companies to drive advancements in drug discovery and digital health.
